Discussion: Our case demonstrates objective evidence for proteinuria induced by lorlatinib, which may also be dose dependent. READ ARTICLE
Journal of Oncology Pharmacy Practice DOI:10.1177/1078155220961549
Authors: Lee CS, Wanchoo R, Seetharamu N.
Discussion: Our case demonstrates objective evidence for proteinuria induced by lorlatinib, which may also be dose dependent. READ ARTICLE
Journal of Oncology Pharmacy Practice DOI:10.1177/1078155220961549
Authors: Lee CS, Wanchoo R, Seetharamu N.